Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mediator complex subunit 11 (MED11) is a protein encoded by the MED11 gene in humans and is a component of the multiprotein Mediator complex[1][5]. This complex functions as a transcriptional coactivator, bridging specific regulatory DNA-binding proteins with the RNA polymerase II transcription machinery, thereby facilitating regulated gene expression for nearly all RNA polymerase II-dependent genes[1][5]. The Mediator complex is modular, and MED11 is part of the Head module, which directly interacts with RNA polymerase II and general initiation factors[3], supporting basal transcription. MED11 is evolutionarily conserved across eukaryotes, and its structure is highly similar between yeast and mammals[2]. Mutations or disruptions in MED11 have been associated with severe neurological, developmental, and epileptic disorders in humans[1]. There are no known interacting drugs targeting MED11, and it is not currently considered a therapeutic target in pharmacology.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mediator complex subunit 11 (MED11).